Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy
To access this article, please choose from the options below
Conflict of interest (all authors): none.
Financial disclosures (all authors): none.
PII: S1538-4721(10)00254-0
doi:10.1016/j.brachy.2010.06.009
© 2011 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
